1. Home
  2. CELU vs ONMD Comparison

CELU vs ONMD Comparison

Compare CELU & ONMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Celularity Inc.

CELU

Celularity Inc.

HOLD

Current Price

$1.39

Market Cap

36.0M

Sector

Health Care

ML Signal

HOLD

Logo OneMedNet Corp

ONMD

OneMedNet Corp

HOLD

Current Price

$0.93

Market Cap

34.7M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
CELU
ONMD
Founded
2016
2006
Country
United States
United States
Employees
123
22
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
36.0M
34.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CELU
ONMD
Price
$1.39
$0.93
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$6.00
N/A
AVG Volume (30 Days)
108.3K
312.4K
Earning Date
05-07-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$76.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.01
$0.30
52 Week High
$4.35
$4.22

Technical Indicators

Market Signals
Indicator
CELU
ONMD
Relative Strength Index (RSI) 62.14 55.67
Support Level $1.16 $0.87
Resistance Level $1.43 $0.92
Average True Range (ATR) 0.07 0.11
MACD 0.02 0.01
Stochastic Oscillator 87.21 46.13

Price Performance

Historical Comparison
CELU
ONMD

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

About ONMD OneMedNet Corp

OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. OneMedNet's technology has provens the commercial and regulatory viability of imaging Real World Data (as defined below), an emerging market, and provides regulatory-grade, image-centric iRWDTM that exactly matches OneMedNet's life science partners' case selection protocols, paving the way for Real World Evidence.

Share on Social Networks: